(NASDAQ: ABP) Abpro Holdings's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 41.39%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 100.55%.
Abpro Holdings's earnings in 2025 is -$22,476,000.On average, 2 Wall Street analysts forecast ABP's earnings for 2025 to be -$12,954,933, with the lowest ABP earnings forecast at -$12,570,133, and the highest ABP earnings forecast at -$13,468,000. On average, 2 Wall Street analysts forecast ABP's earnings for 2026 to be -$16,193,667, with the lowest ABP earnings forecast at -$15,712,667, and the highest ABP earnings forecast at -$16,835,000.
In 2027, ABP is forecast to generate -$24,290,500 in earnings, with the lowest earnings forecast at -$23,569,000 and the highest earnings forecast at -$25,252,500.